Showing results (421-430 of 479) with videos related to

Sort By:
Pageof 48
Cancer Biomarkers : Section a of Disease Markers|October 30, 2008
Tissue elasticity properties as biomarkers for prostate cancerKenneth Hoyt, Benjamin Castaneda, Man Zhang, et al.
Plos Medicine|September 13, 2017
Sustained effectiveness and cost-effectiveness of Counselling for Alcohol Problems, a brief psychological treatment for harmful drinking in men, delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trialAbhijit Nadkarni, Helen A Weiss, Benedict Weobong, et al.
Drug and Alcohol Dependence|September 2, 2020
Parental supply of sips and whole drinks of alcohol to adolescents and associations with binge drinking and alcohol-related harms: A prospective cohort studyAlexandra Aiken, Philip J Clare, Veronica C Boland, et al.
Brachytherapy|March 2, 2005
Bouquet brachytherapy: feasibility and optimization of conically spaced implantsLei Fu, Wan Sing Ng, Haisong Liu, et al.
Addiction (Abingdon, England)|September 25, 2014
Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT)Nicola Metrebian, Teodora Groshkova, Jennifer Hellier, et al.
Addiction (Abingdon, England)|July 18, 2013
Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practiceJohn Stapleton, Robert West, Peter Hajek, et al.
Harm Reduction Journal|March 22, 2017
The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usualGail Gilchrist, Davina Swan, April Shaw, et al.
The Lancet. Infectious Diseases|September 26, 2016
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013Louisa Degenhardt, Fiona Charlson, Jeff Stanaway, et al.
Trials|April 3, 2014
The effectiveness and cost-effectiveness of lay counsellor-delivered psychological treatments for harmful and dependent drinking and moderate to severe depression in primary care in India: PREMIUM study protocol for randomized controlled trialsVikram Patel, Benedict Weobong, Abhijit Nadkarni, et al.
European Addiction Research|February 3, 2022
Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose WitnessesRebecca McDonald, Sibella Breidahl, Katri Abel-Ollo, et al.
Pageof 48